# FDA 483 - Mission Pharmacal Company - February 07, 2014

Source: https://www.keypedia.com/records/483/mission-pharmacal-company/4a5b0198-5b64-4f4b-8326-3e1ac06b0f95

> FDA 483 for Mission Pharmacal Company on February 07, 2014. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Mission Pharmacal Company
- Inspection Date: 2014-02-07
- Product Type: drugs
- Office Name: Dallas District Office
- Summary: An FDA inspection of Mission Pharmacal Co, a drug manufacturer, identified a repeat observation concerning the lack of written procedures for in-process controls and testing. The firm failed to conduct in-process blend sample testing for prenatal products, exemplified by CitraNatal Assure tablets. This indicates a significant and recurring issue with quality control processes.

## Related Documents

- [483 - 2012-05-25](https://www.keypedia.com/records/483/mission-pharmacal-company/0baf761c-5141-4187-9f2f-099e78a6b8f1)
- [483 - 2019-04-04](https://www.keypedia.com/records/483/mission-pharmacal-company/de4b9fd5-1991-46a8-aef1-60b534e3f5c9)
- [483 - 2022-09-22](https://www.keypedia.com/records/483/mission-pharmacal-company/c1fa42f1-b5d4-43b9-a7ab-c65cbe41084c)

## Related Officers

- [investigator](https://www.keypedia.com/people/diana-l-ayala/4646a3f6-81dc-427c-97e1-dae06ab884d3)
- [Investigator](https://www.keypedia.com/people/lucas-b-leake/f4c191d4-25d1-4eb8-8dc9-4d1aa483a441)

Company: https://www.keypedia.com/companies/mission-pharmacal-company/91da96fe-b7e4-449c-b2cc-53a57bd7f2b6

Office: https://www.keypedia.com/offices/dallas-district-office/2d1ee9ae-c44c-4494-8186-a920a69b98f9